Different risk factors for peripheral vascular calcification between diabetic and non-diabetic haemodialysis patients - importance of glycaemic control

被引:63
作者
Ishimura, E
Okuno, S
Kitatani, K
Kim, M
Shoji, T
Nakatani, T
Inaba, M
Nishizawa, Y
机构
[1] Osaka City Univ, Grad Sch Med, Dept Nephrol, Abeno Ku, Osaka 5458585, Japan
[2] Osaka City Univ, Grad Sch Med, Dept Endocrinol Metab & Mol Med, Osaka 5458585, Japan
[3] Osaka City Univ, Grad Sch Med, Dept Urol, Osaka 5458585, Japan
[4] Shirasagi Hosp Kidney Ctr, Osaka, Japan
关键词
vascular calcification; end-stage renal failure; Type II diabetes; glycaemic control; phosphate;
D O I
10.1007/s00125-002-0920-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim/hypothesis. Although derangements of calcium and phosphate control have been emphasized as important risk factors for vascular calcification in nondiabetic haemodialysis patients, similar risk factors for diabetic haemodialysis patients are not known. We compared factors affecting peripheral vascular calcification between haemodialysis patients with and without diabetes. Methods. We examined 421 patients on maintenance haemodialysis. There were 89 patients with Type II (non-insulin-dependent) diabetes mellitus (53 men and 36 women, 62 +/- 10 years old) and 332 patients without diabetes (192 men and 140 women, 59 +/- 13 years old). Hand roentgenography was carried out, and visible vascular calcification of the hand arteries was evaluated. Results. There were 42 diabetic patients and 45 nondiabetic patients with vascular calcification. The prevalence of vascular calcification in diabetic patients (47.1%) was higher than in non-diabetic patients (13.6%) (p<0.001). In multivariate logistic regression, the main factors affecting vascular calcification in non-diabetic patients were advanced age, longer duration of haemodialysis, increased phosphate concentrations, male gender, and lower predialysis diastolic pressure. In diabetic patients, predictors for vascular calcification were higher values of HbA(1C) and longer duration of haemodialysis. In diabetic patients, a 1% increase in HbA(1C) increased the risk of calcification by 2.1-fold (95% CI 1.282-3.575, p=0.0029). Conclusion/interpretation. We have shown that poor glycaemic control, rather than calcium and phosphate concentrations, is a predictor of peripheral vascular calcification in diabetic patients on haemodialysis. This study emphasizes that glycaemic control remains critical even in diabetic patients with end-stage renal disease.
引用
收藏
页码:1446 / 1448
页数:3
相关论文
共 10 条
  • [1] Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy
    Breyer, JA
    Bain, RP
    Evans, JK
    Nahman, NS
    Lewis, EJ
    Cooper, M
    McGill, J
    Berl, T
    Rohde, R
    Hunsicker, LG
    Lachin, J
    Greenhouse, SW
    Verme, DA
    Turlington, TR
    Burrows, PK
    Wish, J
    Sheehan, J
    Pohl, M
    Berl, T
    Santiago, G
    Hunsicker, L
    Kern, EFO
    Lemann, J
    Blementhal, S
    Bresnahan, BS
    Hebert, L
    Goldfarb, S
    Kobrin, S
    Rodby, R
    Levey, A
    McLaughlin, M
    Williams, M
    McGill, J
    Whittler, F
    Rutecki, G
    Cattran, D
    Lietz, S
    Valaitis, D
    Hano, J
    Maxwell, D
    Porush, J
    Spitalewitz, S
    Shapiro, K
    Adler, S
    Tolchin, N
    Hoy, W
    Bernstein, R
    Svetkey, L
    Sharon, Z
    Rausenbaum, B
    [J]. KIDNEY INTERNATIONAL, 1996, 50 (05) : 1651 - 1658
  • [2] Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients
    Cheung, AK
    Sarnak, MJ
    Yan, GF
    Dwyer, JT
    Heyka, RJ
    Rocco, MV
    Teehan, BP
    Levey, AS
    [J]. KIDNEY INTERNATIONAL, 2000, 58 (01) : 353 - 362
  • [3] Cozzolino M, 2001, J AM SOC NEPHROL, V12, P2511, DOI 10.1681/ASN.V12112511
  • [4] Pathophysiological mechanisms of vascular calcification in end-stage renal disease
    Davies, MR
    Hruska, KA
    [J]. KIDNEY INTERNATIONAL, 2001, 60 (02) : 472 - 479
  • [5] Non-invasive assessments of cardiovascular disease in patients with renal failure
    Goodman, WG
    Salusky, IB
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2001, 10 (03) : 365 - 369
  • [6] Arterial stiffening and vascular calcifications in end-stage renal disease
    Guérin, AP
    London, GM
    Marchais, SJ
    Metivier, F
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (07) : 1014 - 1021
  • [7] Medial artery calcification - A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus
    Lehto, S
    Niskanen, L
    Suhonen, M
    Ronnemaa, T
    Laakso, M
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (08) : 978 - 983
  • [8] O'Hare AM, 2002, J AM SOC NEPHROL, V13, P497, DOI 10.1681/ASN.V132497
  • [9] Cardiac calcification in adult Hemodialysis patients - A link between end-stage renal disease and cardiovascular disease?
    Raggi, P
    Boulay, A
    Chasan-Taber, S
    Amin, N
    Dillon, M
    Burke, SK
    Chertow, GM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (04) : 695 - 701
  • [10] Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    Turner, RC
    Holman, RR
    Cull, CA
    Stratton, IM
    Matthews, DR
    Frighi, V
    Manley, SE
    Neil, A
    McElroy, K
    Wright, D
    Kohner, E
    Fox, C
    Hadden, D
    Mehta, Z
    Smith, A
    Nugent, Z
    Peto, R
    Adlel, AI
    Mann, JI
    Bassett, PA
    Oakes, SF
    Dornan, TL
    Aldington, S
    Lipinski, H
    Collum, R
    Harrison, K
    MacIntyre, C
    Skinner, S
    Mortemore, A
    Nelson, D
    Cockley, S
    Levien, S
    Bodsworth, L
    Willox, R
    Biggs, T
    Dove, S
    Beattie, E
    Gradwell, M
    Staples, S
    Lam, R
    Taylor, F
    Leung, L
    Carter, RD
    Brownlee, SM
    Fisher, KE
    Islam, K
    Jelfs, R
    Williams, PA
    Williams, FA
    Sutton, PJ
    [J]. LANCET, 1998, 352 (9131) : 837 - 853